Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 10

Results: 7

Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 10, p. 773, doi. 10.1007/s40261-024-01395-7

By:

Aslanis, Vassilios;
Gray, Michael;
Slack, Robert J.;
Zetterberg, Fredrik R.;
Tonev, Dimitar;
Phung, De;
Smith, Becky;
Jacoby, Brian;
Schambye, Hans;
Krastev, Zahari;
Ungell, Anna-Lena;
Lindmark, Bertil

Publication type:

Article

Neurological and Psychiatric Adverse Events Associated with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer Patients: Insights from a Pharmacovigilance Study via the FDA Adverse Event Reporting System.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 10, p. 789, doi. 10.1007/s40261-024-01396-6

By:

Yu, Zicheng;
Guan, Mengying;
Liao, Xiaolan

Publication type:

Article

Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 10, p. 761, doi. 10.1007/s40261-024-01394-8

By:

Sakamoto, Toshiaki;
Miyamoto, Hirotaka;
Hashizume, Junya;
Akamatsu, Hayato;
Akagi, Tomoaki;
Kodama, Yukinobu;
Hamano, Hirofumi;
Zamami, Yoshito;
Ohyama, Kaname

Publication type:

Article

Correction to: AVT04: An Ustekinumab Biosimilar.

Published in:

2024

By:

Blair, Hannah A.

Publication type:

Correction Notice

Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 10, p. 733, doi. 10.1007/s40261-024-01392-w

By:

Dlott, Anna H.;
Spencer, Sara A.;
Di Pasqua, Anthony J.

Publication type:

Article

The Economic Burden of Atherosclerotic Cardiovascular Disease in Italy.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 10, p. 739, doi. 10.1007/s40261-024-01365-z

By:

Mennini, Francesco S.;
Scortichini, Matteo;
Colivicchi, Furio;
Maggioni, Aldo P.;
Sciattella, Paolo

Publication type:

Article

Comparative Cost-Effectiveness of Atezolizumab Versus Durvalumab as First-Line Combination Treatment with Chemotherapy for Patients with Extensive-Disease Small-Cell Lung Cancer in Japan.

Published in:

Clinical Drug Investigation, 2024, v. 44, n. 10, p. 749, doi. 10.1007/s40261-024-01383-x

By:

Kashiwa, Munenobu;
Tsukada, Miho;
Matsushita, Ryo

Publication type:

Article